Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Reduvo

<< Previous

Bullboard Posts

Next >>

Comment by SamV21on Aug 05, 2022 10:49am

104 Views

Post# 34874063

RE:Reduvo

Golddetector back with more BS , getting close to nothing Reduvo number 14 in line will not be till next year if at all , you have no idea what stag of approval or dispproval Reduvo is in , you are the reason many shareholders lost 1000s here , go crawl back under the rock you came from . Scammer , lier, pumper on nothing ! You belong in jail with Guy ! Reduvo is not approved anywhere in the world , it has other names and the composition is different , if it is the same then Guy has been scamming us telling its all his new science.BS all BS

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China